UTAH MEDICAL PRODUCTS, INC. CONSOLIDATED STATEMENT OF INCOME AND COMPREHENSIVE INCOME - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
UTAH MEDICAL PRODUCTS, INC. CONSOLIDATED STATEMENT OF INCOME AND COMPREHENSIVE INCOME
Sales, net	$ 9,710	$ 11,340
Cost of goods sold	4,172	4,574
Gross profit	5,538	6,766
Operating expense
Selling, general and administrative	2,231	2,617
Research & development	154	266
Total operating expenses	2,385	2,883
Operating income	3,153	3,883
Other income	705	915
Income before provision for income taxes	3,858	4,798
Provision for income taxes	817	842
Net income	$ 3,041	$ 3,956
Earnings per common share (basic)	$ 0.92	$ 1.09
Earnings per common share (diluted)	$ 0.92	$ 1.09
Shares outstanding (basic)	3,310	3,618
Shares outstanding (diluted)	3,310	3,618
Foreign currency translation net of taxes of $0 in all periods	$ 718	$ (631)
Total comprehensive income	$ 3,759	$ 3,325